Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Expert Review of Molecular Diagnostics|September 11, 2024
How can we improve the successful identification of patients suitable for CAR-T cell therapy?Youqin Feng, Longyuan Wu, Tianning Gu, et al.Kidney Diseases (Basel, Switzerland)|May 16, 2024
CAR-T Cell Therapy: Advances in Kidney-Related DiseasesLongyuan Wu, Youqin Feng, Yue Huang, et al.Cancer Control : Journal of the Moffitt Cancer Center|September 22, 2023
An Improved Nomogram to Reduce False-Positive Biopsy Rates of Breast Imaging Reporting and Data System Ultrasonography Category 4A LesionsLinyue Hai, Youqin Feng, Jingjing Zhao, et al.Science China. Life Sciences|April 6, 2025
Integrating genomic features for prognosis in Chinese patients with B-cell lymphoma following chimeric antigen receptor T-cell therapyLinghui Zhou, Youqin Feng, Ruimin Hong, et al.Cancer Biology & Therapy|June 5, 2026
Neoplastic CD3⁺ B cells remodel the DLBCL tumor microenvironment via single-cell and spatial transcriptomicsMingxiao Lang, Youqin Feng, Li Zhou, et al.Hematological Oncology|September 26, 2021
Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysisMingxiao Lang, Youqin Feng, Xiangrui Meng, et al.Frontiers in Immunology|May 22, 2023
Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myelomaQiqi Zhang, Cheng Zu, Ruirui Jing, et al.Cell Reports. Medicine|February 2, 2024
Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolismYue Huang, Mi Shao, Xinyi Teng, et al.Cell Reports. Medicine|January 10, 2025
CD70-targeted iPSC-derived CAR-NK cells display potent function against tumors and alloreactive T cellsLinqin Wang, Yiyun Wang, Xiangjun He, et al.The New England Journal of Medicine|April 24, 2024
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD ProphylaxisYongxian Hu, Mingming Zhang, Tingting Yang, et al.Pageof 2